- Investing Ideas
- /
- Hong Kong Big Pharma, Big Dividends
Hong Kong Big Pharma, Big Dividends
Results
5
Large pharmaceutical stocks to buy with strong dividend features.
5 companies
CSPC Pharmaceutical Group
Market Cap: HK$105.0b
An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.
1093
HK$9.18
7D
8.3%
1Y
110.1%
Sino Biopharmaceutical
Market Cap: HK$122.1b
An investment holding company, operates as a research and development pharmaceutical conglomerate in the People’s Republic of China.
1177
HK$6.83
7D
7.4%
1Y
138.8%
Grand Pharmaceutical Group
Market Cap: HK$27.7b
An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.
512
HK$7.90
7D
1.3%
1Y
78.3%
China Medical System Holdings
Market Cap: HK$34.3b
An investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.
867
HK$14.20
7D
8.3%
1Y
98.9%
China Resources Pharmaceutical Group
Market Cap: HK$29.0b
An investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.
3320
HK$4.61
7D
2.2%
1Y
-12.9%